SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jurgis Bekepuris who wrote (60604)3/27/2018 4:59:34 PM
From: E_K_S  Read Replies (2) of 78740
 
Did a 35% add to my microcap USNU @ $0.34/share

A profitable penny stock, not too common. Company has 7.8mln shares out w/ $3.5mln in sales growing at 10% and profitable. PE is 5.5 last time I checked. More importantly BV is growing. They made $0.06/share in 2016.

Been following the company for over 2 years. Earnings are reported in next 10 days so adding to my position. We may get a surprise w/ some one time tax gain from new legislation. I will be looking at revenue growth from more patient surgeries.

This is a value play but not known because it is too small to show up on the radar screens. You have to be a long term holder and/or sell after earnings release. I will take 50% off the table if this moves back up above $0.50/share. I did that last year w/ my $0.25/share shares. However, last few quarterly reports were pretty good.

Management owns quite a few shares too.

Since FCF is increasing, I will also see if management decides to open up another facility, pay down debt or even pay a dividend. The new tax legislation may/could help determine what they do. I believe they operate two facilities w/ the hospital as their partner.

U.S. Neurosurgical Holdings, Inc. engages in the acquisition and operation of technologies in medical treatment and diagnosis, through its subsidiaries. It includes stereotactic radiosurgery centers, utilizing gamma knife technology, and holds interests in radiological treatment facilities. The company is headquartered in Rockville, MD.

Three months ended September 30, 2017 Compared to Three Months Ended September 30, 2016

Patient revenue for the three months ended September 30, 2017 was $803,000, an increase of 11% compared to $722,000 the previous year. This increase in revenue was largely due to an increased number of procedures at NYU and a true up to the effective rate per procedure recorded in the third quarter of 2016.

10-Q: U.S. NEUROSURGICAL HOLDINGS, INC.

Good Investing

EKS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext